Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul K. Ng is active.

Publication


Featured researches published by Paul K. Ng.


Hepatology | 2004

Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats.

Christopher J. Parsons; Blair U. Bradford; Clark Pan; Ellen Cheung; Michael Schauer; Andreas Knorr; Barbara Krebs; Sabine Kraft; Stefan Zahn; Bodo Brocks; Nikki Feirt; Baisong Mei; Myung-Sam Cho; Roopa Ramamoorthi; Greg Roldan; Paul K. Ng; Peggy Lum; Claudia Hirth-Dietrich; Adrian Tomkinson; David A. Brenner

Liver fibrosis is characterized by increased synthesis, and decreased degradation, of extracellular matrix (ECM) within the injured tissue. Decreased ECM degradation results, in part, from increased expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1), which blocks matrix metalloproteinase (MMP) activity. TIMP‐1 is also involved in promoting survival of activated hepatic stellate cells (HSCs), a major source of ECM. This study examined the effects of blocking TIMP‐1 activity in a clinically relevant model of established liver fibrosis. Rats were treated with carbon tetrachloride (CCl4), or olive oil control, for 6 weeks; 24 days into the treatment, the rats were administered a neutralizing anti–TIMP‐1 antibody derived from a fully human combinatorial antibody library (HuCAL), PBS, or an isotype control antibody. Livers from CCl4‐treated rats exhibited substantial damage, including bridging fibrosis, inflammation, and extensive expression of smooth muscle α‐actin (α‐SMA). Compared to controls, rats administered anti–TIMP‐1 showed a reduction in collagen accumulation by histological examination and hydroxyproline content. Administration of anti–TIMP‐1 resulted in a marked decrease in α‐SMA staining. Zymography analysis showed antibody treatment decreased the activity of MMP‐2. In conclusion, administration of a TIMP‐1 antibody attenuated CCl4‐induced liver fibrosis and decreased HSC activation and MMP‐2 activity. (HEPATOLOGY 2004.)


Separation Science and Technology | 1976

Optimization of Solute Separation by Diafiltration

Paul K. Ng; John L. Lundblad; Gautam Mitra

Abstract Preliminary consideration suggests that process time in diafiltration can be optimized. A mathematical derivation of the optimum time gives a surprisingly simple general relationship between the bulk concentration and the membrane surface concentration. Experimental values confirm that an optimum value can indeed be obtained.


Transfusion | 1981

Plasma protein fraction. Product improvement studies.

Paul K. Ng; Fournel Ma; Lundblad Jl

The vasodilative effects associated with the use of sodium acetate have been reported in the literature. Preparations of plasma protein fraction (PPF) substantially free of this vasodilator were developed. This paper presents and discusses experimental work on the improved product.


Vox Sanguinis | 1993

Process-scale purification of immunoglobulin M concentrate.

Paul K. Ng; Peter E. O'Rourke; John D. Andersen; Grace C. Tsay; Milton B. Dobkin

An IgM concentrate was purified from Cohn fraction III. Efficiency of euglobin precipitation was shown to be controlled by pH and ionic strength. Prekallikrein activator activity in the product was insignificant. Overall yield from the octanoic acid supernate and purity of the concentrate were 66 ± 8 (n = 16) and 50 ± 5% (n = 16), respectively. Solvent‐detergent treatment to inactivate lipid‐enveloped viruses was demonstrated and implemented into the process. Process studies to control residual virucidal agents and C4a generating activity are presented.


Separation Science and Technology | 1990

Tangential Flow Cell Separation from Mammalian Cell Culture

Paul K. Ng; I. Andrew Obegi

Abstract Tangential flow cell separation from fermenter-derived mammalian cell culture has been studied. The process is governed by transmembrane pressure and interactions of carry-over cells with the membrane. Membrane regeneration and comparison with other cell separation systems were discussed. Higher throughput per unit area over conventional dead end filter was demonstrated.


Archive | 1981

Plasma protein fraction substantially free of acetate ions

Paul K. Ng; Michael A. Fournel


Journal of Pharmaceutical Sciences | 1978

Simultaneous Salt and Ethanol Removal from Human Serum Albumin

Paul K. Ng; Gautam Mitra; John L. Lundblad


Archive | 1981

Cell growth medium supplement

Paul K. Ng; Milton B. Dobkin


Biotechnology and Bioengineering | 1982

Kinetics of heat inactivation of hepatitis B virus‐associated DNA polymerase

Gautam Mitra; Paul K. Ng; A. Laudermilch; John L. Lundblad


Vox Sanguinis | 1994

Hepatitis A Viral Safety of Plasma-Derived Factor VIII Concentrate Koate®-HP

Gautam Mitra; Milton B. Dobkin; M. Dumas; Paul K. Ng; G. Roldan; C. Galloway

Collaboration


Dive into the Paul K. Ng's collaboration.

Top Co-Authors

Avatar

Gautam Mitra

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Laudermilch

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Baisong Mei

University of California

View shared research outputs
Top Co-Authors

Avatar

Blair U. Bradford

University of North Carolina at Chapel Hill

View shared research outputs
Top Co-Authors

Avatar

C. Galloway

University of California

View shared research outputs
Top Co-Authors

Avatar

Christopher J. Parsons

University of North Carolina at Chapel Hill

View shared research outputs
Researchain Logo
Decentralizing Knowledge